Clinical Trials
7 trialsNCT05498792 2026-05-22
Study of CBL0137 in Combination With Ipilimumab and Nivolumab Therapy in Melanoma
Fox Chase Cancer Center
Phase EARLY_PHASE1 Recruiting
NCT07586904 2026-05-14
Efficacy and Safety of Neoadjuvant Cadonilimab Plus High-Dose Recombinant Human Interferon α1b in Stage III/IV Melanoma.
Xijing Hospital
Phase EARLY_PHASE1 Recruiting
NCT06216938 2026-04-13
RP1 in Primary Melanoma to Reduce the Risk of Sentinel Lymph Node Metastasis
University of Pittsburgh
Phase EARLY_PHASE1 Recruiting
NCT04741997 2026-03-02
Adjuvant Therapy Based on Pathologic Response After Neoadjuvant Encorafenib Binimetinib in Melanoma
H. Lee Moffitt Cancer Center and Research Institute
Phase EARLY_PHASE1 Recruiting
NCT06305962 2026-02-19
177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors
Radiopharm Theranostics, Ltd
Phase EARLY_PHASE1 Recruiting
NCT06472661 2025-11-20
Mel 70
University of Virginia
Phase EARLY_PHASE1 Recruiting
NCT05961111 2023-07-27
A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Advanced Solid Tumors
Shanghai Yunying Medical Technology
Phase EARLY_PHASE1 Recruiting